GBT Filed a Continuation Application for its Facial and Body Recognition Patent

GBT Filed a Continuation Application for its Facial and Body Recognition Patent

GBT Technologies Inc. ( OTC PINK: GTCH ) (“GBT” or the “Company”) with GBT Tokenize Corp. (“GBT/Tokenize”) filed a continuation application with the United States Patent and Trademark Office for its facial and body recognition, non-provisional patent.

The continuation application aims to broaden the concept of studying, identifying and recognizing features of an image, such as a human face or body. The application has been assigned serial number 18074655 and the filing date was December 5, 2022. The application describes machine learning techniques to classify human facial and bodily features, enabling security functions like locking and unlocking of smartphones and computers. The methods are designed to learn and identify humans with or without facial or body coverage using advanced geometrical engine analysis.

Picture of admin


Leave a Replay

Related Posts

Sign up for our Newsletter

if you want to keep…. to our newsletter or follow our social media

DISCLAIMER: Certain statements contained in this website may constitute forward-looking statements Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors. The forward-looking statements included in this website represent the Company’s views as of the date of this release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the release.